BLFS BIOLIFE SOLUTIONS INC

Nasdaq Electromedical & Electrotherapeutic Apparatus DE CIK: 0000834365
AI RATING
SELL
65% Confidence

Investment Thesis

Strong 28.9% revenue growth and 77.2% net income improvement are undermined by negative operating cash flow (-$491K) and near-zero operating margin (0.1%), indicating earnings quality concerns and unsustainable profitability. Despite fortress-like balance sheet strength, the company generates minimal returns on its $400.9M asset base, signaling severe operational inefficiency.

Strengths

  • + Exceptional revenue growth of 28.9% YoY with net income surging 77.2%
  • + Fortress balance sheet with 7.30x current ratio, minimal leverage (0.01x D/E), and $22.8M cash reserves
  • + Robust gross margin of 63.6% demonstrates strong unit economics and product pricing power

Risks

  • ! Negative operating cash flow of -$491K despite positive net income signals earnings quality deterioration and working capital strain
  • ! Operating margin of 0.1% reveals severe SG&A/operating expense bloat despite strong gross margins, indicating core business struggles
  • ! Abysmal ROE (0.3%) and ROA (0.3%) show extreme capital inefficiency; company not generating adequate returns from $372.2M equity base

Key Metrics to Watch

Financial Metrics

Revenue
27.5M
Net Income
1.2M
EPS (Diluted)
$0.02
Free Cash Flow
-658.0K
Total Assets
400.9M
Cash
22.8M

Profitability Ratios

Gross Margin 63.6%
Operating Margin 0.1%
Net Margin 4.3%
ROE 0.3%
ROA 0.3%
FCF Margin -2.4%

Balance Sheet & Liquidity

Current Ratio
7.30x
Quick Ratio
5.50x
Debt/Equity
0.01x
Debt/Assets
7.2%
Interest Coverage
6.75x
Long-term Debt
2.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-09T09:46:30.923235 | Data as of: 2026-03-31 | Powered by Claude AI